» Articles » PMID: 2019842

Cognitive Behaviour Therapy in Chronic Fatigue Syndrome

Overview
Date 1991 Feb 1
PMID 2019842
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Fifty patients fulfilling operational criteria for the chronic fatigue syndrome (CFS), and who had been ill for a mean of five years, were offered cognitive behaviour therapy in an open trial. Those fulfilling operational criteria for depressive illness were also offered tricyclic antidepressants. The rationale was that a distinction be drawn between factors that precipitate the illness and those that perpetuate it. Among the latter are cognitive factors such as the belief that physical symptoms always imply tissue damage, and behavioural factors such as persistent avoidance of activities associated with an increase in symptoms. Therapy led to substantial improvements in overall disability, fatigue, somatic and psychiatric symptoms. The principal problems encountered were a high refusal rate and difficulties in treating affective disorders. Outcome depended more on the strength of the initial attribution of symptoms to exclusively physical causes, and was not influenced by length of illness. These results suggest that current views on both treatment and prognosis in CFS are unnecessarily pessimistic. It is also suggested that advice currently offered to chronic patients, to avoid physical and mental activity, is counterproductive.

Citing Articles

Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.

Pires L, Reis C, Mesquita Facao A, Moniri A, Marreiros A, Drummond M JMIR Res Protoc. 2024; 13:e51820.

PMID: 38241071 PMC: 10837758. DOI: 10.2196/51820.


Post-COVID-19 fatigue and health-related quality of life in Saudi Arabia: a population-based study.

Al-Johani M, Khalil R, Al-Mohaimeed Y, Al-Mundarij O, Al-Samani A, Al-Saqry O Front Public Health. 2023; 11:1254723.

PMID: 37869192 PMC: 10585179. DOI: 10.3389/fpubh.2023.1254723.


Post-COVID-19 fatigue: A systematic review.

Joli J, Buck P, Zipfel S, Stengel A Front Psychiatry. 2022; 13:947973.

PMID: 36032234 PMC: 9403611. DOI: 10.3389/fpsyt.2022.947973.


A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue.

Rathi A, Jadhav S, Shah N Medicines (Basel). 2021; 8(9).

PMID: 34564089 PMC: 8472462. DOI: 10.3390/medicines8090047.


Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection.

Townsend L, Dyer A, McCluskey P, OBrien K, Dowds J, Laird E Nutrients. 2021; 13(7).

PMID: 34371940 PMC: 8308626. DOI: 10.3390/nu13072430.


References
1.
WITTENBORN J, Buhler R . Somatic discomforts among depressed women. Arch Gen Psychiatry. 1979; 36(4):465-71. DOI: 10.1001/archpsyc.1979.01780040107012. View

2.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

3.
EDWARDS R . Muscle fatigue and pain. Acta Med Scand Suppl. 1986; 711:179-88. DOI: 10.1111/j.0954-6820.1986.tb08948.x. View

4.
Keefe F, Gil K . Behavioral concepts in the analysis of chronic pain syndromes. J Consult Clin Psychol. 1986; 54(6):776-83. DOI: 10.1037//0022-006x.54.6.776. View

5.
Rozenman D, Eliraz A, Lancet M . [Sexual function in asthmatic women]. Harefuah. 1987; 112(3):121-3. View